Vanderbilt researchers have received a $2.15 million grant to study the amount and activity of “brown fat” in adults, with the aim of understanding its role in metabolic disease and identifying new therapeutic targets.

Underserved patients with sub-optimally controlled type 2 diabetes who were cared for by pharmacists were more adherent to their medication regimen and had better blood sugar control than those who did not have a pharmacist in their care team.

New findings suggest that it might be possible to treat diabetes by regenerating insulin-producing beta cells in the pancreas.

Vanderbilt University researchers have created a zebrafish model of skeletal muscle insulin resistance that could help improve diabetes treatment.

For people with diabetes, watching their waistline is an important way to help control their blood glucose and lower the risk for complications from the illness.

New findings explain why variation in a particular gene is the most important determinant of fasting blood glucose levels in humans.

Vanderbilt Diabetes Day, an annual research symposium, this year featured talks by nationally known researchers and by winners of the Diabetes Scholar awards.